Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients

Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients

Background. The most important task in the field of renal-cell cancer (RCC) treatment results improvement is the search and validation of the markers for its early diagnostics still absent in the clinical practice. It was established that even before the onset and/or detection of RCC the level of ki...

Full description

Bibliographic Details
Main Authors: E. S. Gershtein, D. S. Naberezhnov, A. A. Alferov, Svetlana D. Bezhanova, N. F. Frolova, V. B. Matveev, N. E. Kuslinskii
Format: Article
Language:Russian
Published: ABV-press 2021-02-01
Series:Onkourologiâ
Subjects:
kim-1
blood plasma
renal-cell cancer
benign kidney neoplasm
chronic nephritis
diagnostics
prognosis
Online Access:https://oncourology.abvpress.ru/oncur/article/view/1375

Internet

https://oncourology.abvpress.ru/oncur/article/view/1375

Similar Items